Keywords
Last Name
Institution

HERBERT LEVINE

TitleAdjunct Professor
InstitutionBaylor College of Medicine
DepartmentDepartment of Molecular & Cellular Biology
DivisionMolecular & Cellular Biology
AddressMail Stop BCM 130
Houston TX 77030
vCardDownload vCard

    Collapse Additional Tools and Researcher Information 
    Collapse Verify Publications

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Jolly MK, Kulkarni P, Weninger K, Orban J, Levine H. Phenotypic Plasticity, Bet-Hedging, and Androgen Independence in Prostate Cancer: Role of Non-Genetic Heterogeneity. Front Oncol. 2018; 8:50. PMID: 29560343.
      View in: PubMed
    2. Evans MK, Brown MC, Geradts J, Bao X, Robinson TJ, Jolly MK, Vermeulen PB, Palmer GM, Gromeier M, Levine H, Morse MA, Van Laere SJ, Devi GR. XIAP Regulation by MNK Links MAPK and NF?B Signaling to Determine an Aggressive Breast Cancer Phenotype. Cancer Res. 2018 Apr 01; 78(7):1726-1738. PMID: 29351901.
      View in: PubMed
    3. Jia D, Jolly MK, Tripathi SC, Den Hollander P, Huang B, Lu M, Celiktas M, Ramirez-Peña E, Ben-Jacob E, Onuchic JN, Hanash SM, Mani SA, Levine H. Distinguishing mechanisms underlying EMT tristability. Cancer Converg. 2017; 1(1):2. PMID: 29623961.
      View in: PubMed
    4. Bocci F, Jolly MK, Tripathi SC, Aguilar M, Hanash SM, Levine H, Onuchic JN. Numb prevents a complete epithelial-mesenchymal transition by modulating Notch signalling. J R Soc Interface. 2017 Nov; 14(136). PMID: 29187638.
      View in: PubMed
    5. George JT, Jolly MK, Xu S, Somarelli JA, Levine H. Survival Outcomes in Cancer Patients Predicted by a Partial EMT Gene Expression Scoring Metric. Cancer Res. 2017 11 15; 77(22):6415-6428. PMID: 28947416.
      View in: PubMed
    6. Jolly MK, Ward C, Eapen MS, Myers S, Hallgren O, Levine H, Sohal SS. Epithelial mesenchymal transition (EMT), a spectrum of states: role in lung development, homeostasis and disease. Dev Dyn. 2017 Jun 24. PMID: 28646553.
      View in: PubMed
    7. Tripathi SC, Fahrmann JF, Celiktas M, Aguilar M, Marini KD, Jolly MK, Katayama H, Wang H, Murage EN, Dennison JB, Watkins DN, Levine H, Ostrin EJ, Taguchi A, Hanash SM. MCAM mediates chemoresistance in small cell lung cancer via the PI3K/AKT/SOX2 signaling pathway. Cancer Res. 2017 Jun 23. PMID: 28646020.
      View in: PubMed
    8. Jia D, Jolly MK, Kulkarni P, Levine H. Phenotypic Plasticity and Cell Fate Decisions in Cancer: Insights from Dynamical Systems Theory. Cancers (Basel). 2017 Jun 22; 9(7). PMID: 28640191.
      View in: PubMed
    9. Jolly MK, Boareto M, Debeb BG, Aceto N, Farach-Carson MC, Woodward WA, Levine H. Inflammatory breast cancer: a model for investigating cluster-based dissemination. NPJ Breast Cancer. 2017; 3:21. PMID: 28649661.
      View in: PubMed
    10. Jolly MK, Ware KE, Gilja S, Somarelli JA, Levine H. EMT and MET: necessary or permissive for metastasis? Mol Oncol. 2017 May 26. PMID: 28548345.
      View in: PubMed
    11. Jolly MK, Tripathi SC, Somarelli JA, Hanash SM, Levine H. Epithelial/mesenchymal plasticity: how have quantitative mathematical models helped improve our understanding? Mol Oncol. 2017 May 26. PMID: 28548388.
      View in: PubMed
    12. Jia D, Jolly MK, Harrison W, Boareto M, Ben-Jacob E, Levine H. Operating principles of tristable circuits regulating cellular differentiation. Phys Biol. 2017 May 23; 14(3):035007. PMID: 28443829.
      View in: PubMed
    13. Ware KE, Gilja S, Xu S, Shetler S, Jolly MK, Wang X, Bartholf Dewitt S, Hish AJ, Jordan S, Eward W, Levine H, Armstrong AJ, Somarelli JA. Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells. J Vis Exp. 2017 04 07; (122). PMID: 28448023.
      View in: PubMed
    14. Kulkarni P, Jolly MK, Jia D, Mooney SM, Bhargava A, Kagohara LT, Chen Y, Hao P, He Y, Veltri RW, Grishaev A, Weninger K, Levine H, Orban J. Phosphorylation-induced conformational dynamics in an intrinsically disordered protein and potential role in phenotypic heterogeneity. Proc Natl Acad Sci U S A. 2017 Mar 28; 114(13):E2644-E2653. PMID: 28289210.
      View in: PubMed
    15. Mooney SM, Talebian V, Jolly MK, Jia D, Gromala M, Levine H, McConkey BJ. The GRHL2/ZEB Feedback Loop-A Key Axis in the Regulation of EMT in Breast Cancer. J Cell Biochem. 2017 Mar 07. PMID: 28266048.
      View in: PubMed
    16. Somarelli JA, Shetler S, Jolly MK, Wang X, Bartholf Dewitt S, Hish AJ, Gilja S, Eward WC, Ware KE, Levine H, Armstrong AJ, Garcia-Blanco MA. Mesenchymal-Epithelial Transition in Sarcomas Is Controlled by the Combinatorial Expression of MicroRNA 200s and GRHL2. Mol Cell Biol. 2016 Oct 01; 36(19):2503-13. PMID: 27402864; PMCID: PMC5021378 [Available on 03/12/17].
    17. Mooney SM, Jolly MK, Levine H, Kulkarni P. Phenotypic plasticity in prostate cancer: role of intrinsically disordered proteins. Asian J Androl. 2016 Sep-Oct; 18(5):704-10. PMID: 27427552; PMCID: PMC5000791.
    18. Jolly MK, Tripathi SC, Jia D, Mooney SM, Celiktas M, Hanash SM, Mani SA, Pienta KJ, Ben-Jacob E, Levine H. Stability of the hybrid epithelial/mesenchymal phenotype. Oncotarget. 2016 May 10; 7(19):27067-84. PMID: 27008704.
      View in: PubMed
    19. Boareto M, Jolly MK, Goldman A, Pietilä M, Mani SA, Sengupta S, Ben-Jacob E, Levine H, Onuchic JN. Notch-Jagged signalling can give rise to clusters of cells exhibiting a hybrid epithelial/mesenchymal phenotype. J R Soc Interface. 2016 May; 13(118). PMID: 27170649; PMCID: PMC4892257.
    20. Grigore AD, Jolly MK, Jia D, Farach-Carson MC, Levine H. Tumor Budding: The Name is EMT. Partial EMT. J Clin Med. 2016 Apr 29; 5(5). PMID: 27136592; PMCID: PMC4882480.
    21. Tripathi SC, Peters HL, Taguchi A, Katayama H, Wang H, Momin A, Jolly MK, Celiktas M, Rodriguez-Canales J, Liu H, Behrens C, Wistuba II, Ben-Jacob E, Levine H, Molldrem JJ, Hanash SM, Ostrin EJ. Immunoproteasome deficiency is a feature of non-small cell lung cancer with a mesenchymal phenotype and is associated with a poor outcome. Proc Natl Acad Sci U S A. 2016 Mar 15; 113(11):E1555-64. PMID: 26929325; PMCID: PMC4801290.
    22. Jolly MK, Jia D, Boareto M, Mani SA, Pienta KJ, Ben-Jacob E, Levine H. Coupling the modules of EMT and stemness: A tunable 'stemness window' model. Oncotarget. 2015 Sep 22; 6(28):25161-74. PMID: 26317796; PMCID: PMC4694822.
    23. Jolly MK, Boareto M, Huang B, Jia D, Lu M, Ben-Jacob E, Onuchic JN, Levine H. Implications of the Hybrid Epithelial/Mesenchymal Phenotype in Metastasis. Front Oncol. 2015; 5:155. PMID: 26258068; PMCID: PMC4507461.
    24. Jia D, Jolly MK, Boareto M, Parsana P, Mooney SM, Pienta KJ, Levine H, Ben-Jacob E. OVOL guides the epithelial-hybrid-mesenchymal transition. Oncotarget. 2015 Jun 20; 6(17):15436-48. PMID: 25944618; PMCID: PMC4558162.
    25. Jolly MK, Huang B, Lu M, Mani SA, Levine H, Ben-Jacob E. Towards elucidating the connection between epithelial-mesenchymal transitions and stemness. J R Soc Interface. 2014 Dec 6; 11(101):20140962. PMID: 25339690; PMCID: PMC4223923.
    26. Lu M, Jolly MK, Levine H, Onuchic JN, Ben-Jacob E. MicroRNA-based regulation of epithelial-hybrid-mesenchymal fate determination. Proc Natl Acad Sci U S A. 2013 Nov 05; 110(45):18144-9. PMID: 24154725; PMCID: PMC3831488.
    27. Sangi-Haghpeykar H, Poindexter AN, Levine H. Sperm transport and survival post-application of a new spermicide contraceptive. Advantage 24 Study Group. Contraception. 1996 Jun; 53(6):353-6. PMID: 8773422.
      View in: PubMed
    28. Poindexter AN, Levine H, Sangi-Haghpeykar H, Frank ML, Grear A, Reeves KO. Comparison of spermicides on vulvar, vaginal, and cervical mucosa. Contraception. 1996 Mar; 53(3):147-53. PMID: 8689878.
      View in: PubMed
    LEVINE's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description